11月28日，据行业媒体《食品内参》报道，广药王老吉拿到了泰国天丝牛磺酸红牛在中国5个省份的经 销权，且已经开始积极布局。有信源称，第一波5个省份为湖南、海南、江西、广东、广西。 对此，南都湾财社记者向王老吉方面求证，王老吉大健康公司公关部表示，公司近期与天丝红牛达成了 某些省份的经销合作，已成立专门的事业部来开展相关业务。 南都湾财社记者同样向天丝集团方面求证，截至发稿前未收到回复。 王老吉确认与天丝红牛合作 但否认"销售目标5亿以上" 据报道，天丝集团与王老吉合作的契机是"原广药王老吉董事长徐文流退休后被天丝红牛聘用为董事 长；如今，徐文流利用他在广药的人脉，要求王老吉现有经销商全面接手做牛磺酸红牛……"，对此， 王老吉方面否认了这一说法。 上述报道还提到，针对与天丝集团的合作，王老吉方面制定了销售目标——2025年11—12月份，月销售 目标为80万箱；2026年销售目标5亿以上（后期根据确定区域再拟定）。但在采访回复中，王老吉方面 同样否认制定销售目标，表示"都是假的"。 而对于具体的合作形式、内容、目标等，王老吉与天丝集团方面均未回复。 中泰红牛缠斗已久 王老吉的加入释放何种信号？ 针对广药王老吉与 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 須予披露的交易：出售應收賬款 本次交易 於2025年11月28日，廣州醫藥與興證資管根據基礎資產買賣協議（第四期）簽訂《新增基礎資產交 割確認函》，確認向興證資管出售第五次新增基礎資產，並收到購買價款人民幣440,280,622.20 元。 本公司根據上市規則第14.07條單獨計算有關本次交易的所有適用百分比率低於5%，故本次交易 單獨並不構成本公司的須予公佈的交易，無須根據上市規則第十四章遵守任何披露規定。 然而，根據上市規則第14.22條，如一連串交易全部均於12個月內完成或屬彼此相關者，則該等交 易應合併計算，並視作一項交易處理。鑒於本次交易及過往交易均由廣州醫藥與興證資管於12個 月內訂立，並且交易性質相似，就計算相關百分比率而言，該等交易應根據上市規則第14.22條進 行合併。 由於根據上市規則第14.07條就本次交易及過往交易按合併基準計算的最高適用百分比率高於5% 但低於25%，因此，本次 ...

智通财经APP讯，白云山(00874)发布公告，于2025年11月28日，广州医药与兴证资管根据基础资产买卖 协议(第四期)签订《新增基础资产交割确认函》，确认向兴证资管出售第五次新增基础资产(其为账面值 人民币4.42亿元的应收账款)，并收到购买价款人民币4.4亿元。 广州医药通过该等交易项下的交易利用应收账款进行资产证券化，可以将应收账款转变为流动性较高的 现金资产，达到盘活资产存量的目的。鉴于上述原因及本公告所披露的该等交易的条款，董事会认为该 等交易的条款属公平合理，符合本集团及本公司股东的整体权益。 ...

Core Viewpoint - The announcement highlights the sale of receivables by Guangzhou Pharmaceutical to Xingzheng Asset Management, which is part of an asset securitization strategy aimed at enhancing liquidity and optimizing asset utilization [1] Group 1: Transaction Details - Guangzhou Pharmaceutical confirmed the sale of receivables with a book value of RMB 442 million to Xingzheng Asset Management, receiving a purchase price of RMB 440 million [1] - This transaction is part of the fourth phase of a foundational asset sale agreement, indicating a structured approach to asset management [1] Group 2: Strategic Implications - The transaction allows Guangzhou Pharmaceutical to convert receivables into cash, thereby improving liquidity and enabling better asset management [1] - The board of directors considers the terms of the transaction to be fair and reasonable, aligning with the overall interests of the company and its shareholders [1]

广东各界捐款捐物驰援香港火灾救援 中新网广州11月28日电 (记者 蔡敏婕)香港大埔宏福苑26日发生火灾，灾情牵动社会各界的心。广东各 界捐款捐物驰援香港火灾救援。 梁冠军表示，希望通过这次捐赠行动，能够激发更多海内外华侨华人的善心与义举，汇聚成一股强大的 正能量，为香港受灾同胞送去实质性的帮助与温暖。(完) 来源：中国新闻网 编辑：张澍楠 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 连日来，广东多家企业及个人捐款捐物驰援火灾救援。广药白云山28日宣布，携旗下王老吉大健康公司 捐赠价值500万港元的现金及物资，紧急驰援香港大埔灾后救助。 喜茶宣布捐赠500万港元，支援受灾居民救助、后续安置保障和重建等系列工作。 小鹏汽车官方宣布，捐赠500万港元驰援香港大埔火灾救援，支持受灾家庭渡过难关。 长隆集团捐赠1000万元人民币，用于受灾人群的紧急救援与过渡安置，并助力灾后社区的恢复工作。 视源股份捐款200万元人民币，捐款将用于受灾家庭的紧急救援与过渡安置，并助力灾后社区的恢复工 作。 中华海外联谊会副会长、广州软件学院董事长梁冠军以个人名义捐款100万元人民币，专项用于此次大 埔火灾受灾 ...

Core Viewpoint - The company, Baiyunshan (00874.HK), has announced a transaction involving the sale of additional underlying assets to Xingzheng Asset Management for a total purchase price of RMB 440,280,622.20, aimed at enhancing liquidity through asset securitization [1] Group 1: Transaction Details - Baiyunshan's non-wholly owned subsidiary, Guangzhou Pharmaceutical, signed a "New Underlying Asset Delivery Confirmation" with Xingzheng Asset Management based on the asset sale agreement (Phase IV) [1] - The transaction involves the sale of the fifth batch of additional underlying assets, confirming the financial terms and conditions of the deal [1] Group 2: Financial Implications - The transaction allows Guangzhou Pharmaceutical to utilize accounts receivable for asset securitization, converting receivables into more liquid cash assets [1] - The board of directors considers the terms of the transaction to be fair and reasonable, aligning with the overall interests of the group and its shareholders [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 茲提述本公司日期為2024年10月23日、11月28日、2025年2月28日、2025年5月28日及2025年8月 28日內容有關過往交易的公告。除非文意另有所指，否則本公告所用詞彙的涵義與上述公告內 所界定者相同。 須予披露的交易：出售應收賬款 本次交易 2. 本次交易及過往交易 於2025年11月28日，廣州醫藥與興證資管根據基礎資產買賣協議（第四期）簽訂《新增基礎資產交 割確認函》，確認向興證資管出售第五次新增基礎資產，並收到購買價款人民幣440,280,622.20 元。 上市規則的含義 本公司根據上市規則第14.07條單獨計算有關本次交易的所有適用百分比率低於5%，故本次交易 單獨並不構成本公司的須予公佈的交易，無須根據上市規則第十四章遵守任何披露規定。 然而，根據上市規則第14.22條，如一連串交易全部均於12個月內完成或屬彼此相關者，則該等交 易應合併計算，並視作一項交易處理。鑒於本次交易 ...

本报讯(记者王镜茹)11月26日下午，中国香港新界大埔屋邨宏福苑多栋住宅楼发生火灾，造成重大人员 伤亡。 灾情发生后，广州白云山医药集团股份有限公司(以下简称"白云山")第一时间紧急响应，迅速调配资 源，携旗下广州王老吉大健康产业有限公司捐赠价值500万港元的现金及物资，紧急驰援灾后救助，以 实际行动助力香港受灾同胞渡过难关，为灾后援助贡献力量。 广药白云山，爱心满人间。白云山将密切关注灾情后续进展，与香港同胞同根同心，协力共渡难关。 ...

Group 1 - The core project of Guanghua Pharmaceutical, "Children's Xiao Chai Hu Granules for treating pediatric gastrointestinal colds," has officially launched its Phase II clinical research in Tianjin, marking a significant step in traditional Chinese medicine for this indication [1] - This study is the first to apply the classic formula Xiao Chai Hu Decoction systematically for treating pediatric gastrointestinal colds, utilizing a randomized, double-blind, parallel-controlled modern evidence-based medical approach to explore the efficacy and safety of the treatment [1] - Currently, there are no similar products for children's Xiao Chai Hu Granules available in the market, indicating a potential gap in the market for pediatric proprietary Chinese medicine in this disease area [1] Group 2 - Guanghua Pharmaceutical has established multiple innovation platforms, including a doctoral workstation in Guangdong Province and a provincial enterprise technology center, and has applied for 22 core invention patents for its flagship product, Baiyunshan Xiao Chai Hu Granules [2] - The fingerprint detection method for Xiao Chai Hu Granules has been included in the 2025 edition of the Chinese Pharmacopoeia, showcasing the company's commitment to quality and innovation [2] - In response to a recent fire incident in Hong Kong, the company promptly mobilized resources and donated cash and materials worth 5 million HKD to support disaster relief efforts [2]

Core Viewpoint - Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. announced the inclusion of its subsidiary Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.'s land and fixed assets into the land reserve plan, with a total compensation amount of approximately 375.24 million yuan and an additional land transfer reward of about 73.32 million yuan, totaling approximately 448.57 million yuan [1][2]. Group 1 - The land and fixed assets of Guanghua Pharmaceutical located at No. 355, Shatai North Road, Baiyun District, Guangzhou, have been included in the land reserve plan [1][2]. - The compensation agreement was signed on November 27, 2025, with the Baiyun District People's Government, and the total compensation amount is 375,244,134 yuan [1][2]. - The compensation includes approximately 366,618,840 yuan for land included in the "Three Olds" renovation program and 8,625,294 yuan for land not included in this program [2]. Group 2 - The total compensation and land transfer reward amount to approximately 448,567,902 yuan, contingent upon meeting the "net land" standards [1][2]. - The transaction does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations [1][3]. - The transaction was approved by the company's Strategic Development and Investment Committee, and does not require further approval from the board or shareholders [3]. Group 3 - The land area involved in the transaction is 29,429.56 square meters, with a total building area of 10,530.35 square meters, including offices, workshops, and warehouses [6]. - The land has a clear ownership status, with no existing mortgages or legal restrictions [7]. - The land was acquired in 2002 with a usage period of 50 years, and has been depreciated for 23 years [8]. Group 4 - The compensation pricing is based on evaluations from two real estate appraisal firms, with the average land price used to determine the compensation amount [9][10]. - The compensation for the "Three Olds" portion is calculated at 50% of the market assessed land price, resulting in approximately 366,618,840 yuan [9]. - The non-"Three Olds" portion is evaluated at approximately 8,625,294 yuan based on different appraisal methods [10]. Group 5 - The agreement stipulates that the first compensation payment of 80 million yuan will be made after the land ownership is deregistered, with subsequent payments contingent on land transfer completion [13]. - The company plans to manage logistics through warehouse leasing during the transition period, ensuring no personnel displacement [15]. - The land reserve will not lead to related party transactions or competition within the industry [15].